Clinical Trial Update: An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AZD2014 alone and with rituximab in relapsed/refractory diffuse large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• AZD2014 (vistusertib)
• Rituximab (rituximab)

Snippet

Sponsor: University of Birmingham | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: COMPLETED